McCann Katy J, Ottensmeier Christian H, Callard Alice, Radcliffe Catherine M, Harvey David J, Dwek Raymond A, Rudd Pauline M, Sutton Brian J, Hobby Paul, Stevenson Freda K
Genetic Vaccine Group, Cancer Sciences Division, University of Southampton School of Medicine, Southampton, UK.
Mol Immunol. 2008 Mar;45(6):1567-72. doi: 10.1016/j.molimm.2007.10.009. Epub 2007 Nov 19.
Follicular lymphoma (FL) generally expresses immunoglobulin (Ig) with somatically mutated variable (V) region genes. Surprisingly, these almost always carry introduced motifs available for N-glycosylation (Asn-X-Ser/Thr). Introduced motifs are uncommon on normal B cells, but are on other germinal center (GC)-associated B-cell malignancies suggesting a site-specific role. They are not evident in mutated chronic lymphocytic leukemia (CLL) or myeloma. Recently, we found that the glycosylation sites are unusual in containing oligomannose glycans, which are apparently displayed on tumor cell surface IgM. This suggests a potential interaction with a mannose receptor in the GC. However, natural N-glycosylation sites exist in germline (GL) V region genes, particularly the V4-34 gene expressed by normal B cells and by some malignancies, including CLL, potentially undermining the selective importance for FL. To compare oligosaccharide addition at the introduced and natural sites, we expressed V region genes as single chain Fv (scFv) and analyzed the added glycans. In contrast to introduced sites, which were oligomannosylated, the natural GL motif in the V4-34 sequence had no added sugars. The remarkable selective glycosylation within the heavy chain V region gene of FL apparently permits only limited processing to oligomannose at somatically mutated motifs, creating a feature exploitable by GC lymphomas.
滤泡性淋巴瘤(FL)通常表达具有体细胞突变可变(V)区基因的免疫球蛋白(Ig)。令人惊讶的是,这些免疫球蛋白几乎总是带有可用于N-糖基化的引入基序(天冬酰胺- X -丝氨酸/苏氨酸)。引入基序在正常B细胞上并不常见,但在其他生发中心(GC)相关的B细胞恶性肿瘤中存在,提示其具有位点特异性作用。在突变的慢性淋巴细胞白血病(CLL)或骨髓瘤中则不明显。最近,我们发现这些糖基化位点含有低聚甘露糖聚糖,这一情况不同寻常,且这些聚糖显然展示在肿瘤细胞表面的IgM上。这表明在生发中心可能与甘露糖受体存在潜在相互作用。然而,种系(GL)V区基因中存在天然N-糖基化位点,特别是正常B细胞以及包括CLL在内的一些恶性肿瘤所表达的V4-34基因,这可能会削弱FL中该位点的选择性重要性。为了比较在引入位点和天然位点的寡糖添加情况,我们将V区基因表达为单链Fv(scFv)并分析添加的聚糖。与被低聚甘露糖基化的引入位点不同,V4-34序列中的天然GL基序没有添加糖类。FL重链V区基因内显著的选择性糖基化显然仅允许对体细胞突变基序进行有限的加工形成低聚甘露糖,从而产生了一种可供GC淋巴瘤利用的特征。